Singapore Contract Research Organization Market

Singapore will Remain in the Global Spotlight as the Strategic Hub of the CRO Market in APAC.

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
12-Aug-2015
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
9AB9-00-31-00-00
SKU
LS00072-GL-MR_16913
Yes
SHARE

Singapore Contract Research Organization Market
Published on: 12-Aug-2015 | SKU: LS00072-GL-MR_16913

Need more details?

$1,500.00

$1,125.00 save 25 %

DownloadLink
Need more details?

This market insight presents an overview and analysis of the Singaporean CRO market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The research study discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study covers the complete life cycle of the CRO industry, from preclinical trials to post-marketing surveillance. It provides detailed information on support services, such as central laboratory services, bio-analytics, and data management. The market insight also analyses Market Engineering measurements, and R&D trends.

Key Findings

Key Findings (continued)

Total CRO Market Size by Stages of Clinical Development

Market Size Estimation Methodology

Scope and Segmentation

Key Questions This Study Will Answer

Total CRO Market—Market Engineering Measurements

CEO’s Perspective

CEO’s Perspective

Key Companies to Watch (continued)

Pharmaceutical Market Overview

Pharmaceutical Market Overview (continued)

Market Perspective

Clinical Trials Market Overview

Clinical Trials Market Overview (continued)

Clinical Trials Scenario

Profiles of Clinical Trials

Total CRO Market Segmentation by Stages of Clinical Development

Forecast Assumptions

Market Engineering Measurements

Total CRO Market—Revenue Forecast

Revenue Forecast Discussion

Total CRO Market—Phase I & Phase II

Total CRO Market—Phase III & Phase IV

Total CRO Market—Preclinical Revenue Forecast

Preclinical Revenue Forecast Discussion

Total CRO Market—Data Management Revenue Forecast

Data Management Revenue Forecast Discussion

Total CRO Market—Biostatistics Revenue Forecast

Biostatistics Revenue Forecast Discussion

Total CRO Market—Central Laboratory Services Revenue Forecast

Central Laboratory Services Revenue Forecast Discussion

Total CRO Market—Pharmacovigilance Revenue Forecast

Pharmacovigilance Revenue Forecast Discussion

Total CRO Market—Bioanalytics Revenue Forecast

Bioanalytics Revenue Forecast Discussion

Total CRO Market—HEOR Revenue Forecast

HEOR Revenue Forecast Discussion

Total CRO Market—Key Trends

Clinical Research Regulatory Overview

Clinical Research Regulatory Overview (continued)

Clinical Research Regulatory Process

Competitive Structure

Competitive Analysis—Selected Key Market Participants

Competitive Analysis—Selected Key Market Participants (continued)

Competitive Analysis—Selected Key Market Participants (continued)

Competitive Analysis—Selected Key Market Participants (continued)

Competitive Analysis—Selected Key Market Participants (continued)

The Last Word—Discussion

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are broadly segmented into bronchodilators, anti-inflammatories, and combination therapies of current global interest. Novel inhaler devices, formulations, and anti-inflammatories are key drivers for the market.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Sanjeev Kumar
WIP Number 9AB9-00-31-00-00
Is Prebook No

Singapore Contract Research Organization Market

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
LS00072-GL-MR_16913